A water pill that has worked for years is replaced by one with a different name, and nobody explains why. Furosemide (Lasix), bumetanide (Bumex) and torsemide (Demadex) are three loop diuretics that do the same job by slightly different routes. The differences are real, but they are smaller than the box on the pharmacy bag suggests.
All three are used to treat fluid build-up (edema) from heart failure, kidney disease or liver disease, and each label carries a warning about excessive diuresis causing water and electrolyte loss. A change from one to another is a prescriber decision made with lab results and a weight or symptom history; there is no safe do-it-yourself swap, and tablet counts are not interchangeable.
Switches usually happen for one of a few reasons: swelling that is not clearing, a pattern of unpredictable results, a change in kidney function, a hospital discharge that uses a different formulary, or a plan to reduce the number of urgent bathroom trips. Understanding which applies to you turns a confusing label change into a useful conversation.
What the three labels say
| Feature | Furosemide (Lasix) | Bumetanide (Bumex) | Torsemide |
|---|---|---|---|
| Labeled uses | Edema from heart failure, cirrhosis and kidney disease; oral use in hypertension | Edema from heart failure, hepatic and renal disease including nephrotic syndrome | Edema from heart failure, renal or hepatic disease; hypertension |
| Onset after oral dose | Within 1 hour; peak in the first or second hour | 30 to 60 minutes; peak 1 to 2 hours | Within 1 hour; peak in the first or second hour |
| Duration of effect | 6 to 8 hours | At usual doses largely complete within 4 hours | About 6 to 8 hours |
| Absorption from tablets | Mean bioavailability 64% of an intravenous dose (fasted normal men) | Rapidly eliminated; half-life 1 to 1.5 hours | Bioavailability about 80% with little first-pass metabolism |
| Half-life | About 2 hours | 1 to 1.5 hours | About 3.5 hours |
| Potency statement | Reference loop diuretic | Label: 1 mg has diuretic potency equivalent to approximately 40 mg furosemide | Not stated in the label sections reviewed |
| Boxed or headline warning | Potent diuretic; excessive amounts can cause profound diuresis with water and electrolyte depletion | Same warning | Warnings for volume depletion, electrolyte problems, ototoxicity |
The Bumex potency line is a statement from the label about the drug’s pharmacology. It should not be read as a conversion chart for a patient. The doses used in practice depend on kidney function, the condition being treated and response, and clinicians adjust them from lab values and symptoms. Sources: Lasix, Bumex and torsemide labels on DailyMed.
Why absorption matters more than potency
The most common clinical rationale offered for moving from furosemide is its variable absorption. The Lasix label reports a mean oral bioavailability of 64% in fasted normal men, with peak levels reached in about 87 minutes for the tablet. In people with heart failure, gut swelling can slow and reduce absorption, which is one proposed reason a prescriber might favor an agent with more consistent absorption. Torsemide’s label reports about 80% bioavailability with small variation between people; the Bumex label sections we reviewed do not give a bioavailability percentage, so we do not compare it on this point.
Longer action is a second candidate. Torsemide’s half-life is about 3.5 hours against roughly 2 hours for furosemide and 1 to 1.5 hours for bumetanide. Duration of diuresis is similar for furosemide and torsemide (6 to 8 hours), but the shorter half-lives of the other agents do not translate neatly into patient experience, because the clinical effect depends on the amount of drug reaching the kidney tubule, not on plasma levels alone.
Does one work better? The trial evidence
For heart failure, the largest pragmatic comparison is the TRANSFORM-HF trial, which randomized 2,859 patients hospitalized with heart failure across 60 US hospitals to a strategy of torsemide or furosemide. According to the abstract of a 2026 secondary analysis on PubMed, the main analysis showed neutral effects on all-cause death at 30 months and on the composite of death and first rehospitalization at 12 months, and the secondary win-ratio analysis also found no significant difference (adjusted ratio 1.07, 95% CI 0.98 to 1.16). The authors describe those findings as exploratory and not establishing superiority of either strategy.
In plain terms: on the main outcomes studied, switching to torsemide did not clearly help or harm a group of hospitalized patients, so a prescriber who prefers torsemide for an individual is working from judgment about that person, not from a proven across-the-board advantage. We did not find comparable large trials for bumetanide in the sources we opened.
The sulfonamide-allergy caution appears in the Lasix and Bumex labels. Tinnitus and hearing loss are noted for loop diuretics, with higher risk at higher-than-recommended doses, severe kidney impairment, low albumin, or alongside aminoglycoside antibiotics. All three drugs can lower potassium, sodium, magnesium and calcium and raise blood sugar or uric acid.
Reasons your prescriber may have switched
- Persistent swelling or weight gain on furosemide. A more reliably absorbed drug is one response, alongside diet, fluid and medicine review.
- Kidney function changes. The labels discuss dehydration and worsening renal function with excessive diuresis; the choice and the monitoring plan shift with eGFR.
- Timing and lifestyle. A drug with a different duration may fit work, travel or sleep better.
- Hospital formulary. The discharge medication can reflect what the hospital stocks. Ask whether the change was intended to continue.
- Tolerability. Cramps, dizziness, low potassium or hearing symptoms may prompt a trial of another agent.
- Insurance. A formulary change is a common non-clinical cause. Ask the pharmacist if it is.
Why timing can feel different after a switch
Because the labels give different durations, a switch can change when you need a bathroom. Lasix reports diuresis lasting 6 to 8 hours, torsemide about 6 to 8 hours, and Bumex says that at usual doses diuresis is largely complete within 4 hours, with onset within 30 to 60 minutes. A shorter duration can make a late-day dose less disruptive to sleep or longer travel more predictable; a longer one can do the opposite. These are label descriptions, and individual responses vary with kidney function and fluid status. It is reasonable to tell the prescriber how the new schedule fits your day, and to ask whether the timing of the dose can move, without moving it yourself.
Questions to ask at the handoff
- What was the reason for the change, and what result will tell us it worked?
- Do I stay on the old pill too, or does the new one fully replace it?
- How will my weight, blood pressure, potassium and kidney tests be checked in the next weeks? Our guide on furosemide and daily weight explains what a log can and cannot tell you.
- Do I need potassium or magnesium checked? See furosemide and low potassium.
- What do I do on days with vomiting, diarrhea or poor intake? Ask for written sick-day instructions.
- Which warning signs mean a same-day call: dizziness on standing, very low urine output, new muscle cramps, ringing in the ears or hearing change?
Safety points that apply to the whole class
The Lasix and Bumex labels both open with a boxed warning that these are potent diuretics which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion, and that careful medical supervision is required. Torsemide’s label states excessive diuresis may cause symptomatic dehydration, blood volume reduction, hypotension and worsening renal function, particularly in salt-depleted patients or those taking renin-angiotensin-aldosterone inhibitors.
Older adults get extra attention. The Bumex label reports lower bumetanide clearance in a group of geriatric subjects aged 65 to 73 and higher peak levels, while the Lasix label notes that furosemide binding to albumin may be reduced in elderly patients and that renal clearance is smaller in older men. For a caregiver view, see our caregiver guide to Lasix side effects in older adults; our existing page on diuretics, potassium and dehydration covers the monitoring basics.
Monitoring that goes with any switch
The torsemide label asks prescribers to monitor volume status and renal function periodically, and serum electrolytes and blood glucose periodically, because the drug can cause symptomatic hypokalemia, hyponatremia, hypomagnesemia, hypocalcemia and hypochloremic alkalosis, can raise blood glucose, and can cause worsening renal function particularly in salt-depleted patients or with renin-angiotensin-aldosterone inhibitors or nephrotoxic drugs including aminoglycosides, cisplatin and NSAIDs. The Lasix label makes similar points: reversible BUN elevations associated with dehydration, hyperglycemia on occasion, and hypokalemia with brisk diuresis, inadequate oral electrolyte intake, cirrhosis, or concomitant corticosteroids, laxatives or large amounts of licorice. That is the lab and symptom checklist a new water pill inherits, so it is reasonable to ask when the first blood test after the switch is due.
Gout is an easily missed example. The torsemide label states that asymptomatic hyperuricemia can occur and gout may rarely be precipitated, and the Bumex label notes that Bumex decreases uric acid excretion and increases serum uric acid. A new painful joint after a switch is worth reporting rather than attributing to age.
What not to do
- Do not take an old and a new loop diuretic together unless told to. Duplicating water pills is a way to end up dehydrated with low electrolytes.
- Do not convert strengths yourself, because tablets differ in milligrams and effect.
- Do not stop a diuretic because you feel fine; fluid can return quickly in heart failure.
- Do not add potassium supplements or salt substitutes without checking, since the right direction depends on your labs and other medicines.
Sources
- DailyMed: Lasix (furosemide) tablets label
- DailyMed: Bumex (bumetanide) tablets label
- DailyMed: Torsemide tablets label
- PubMed: Win-ratio reanalysis of the TRANSFORM-HF trial
Evidence checked October 30, 2026. General information only; do not change, combine or stop a diuretic without your prescriber.